• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用T细胞记忆有效靶向新冠病毒。

Employing T-Cell Memory to Effectively Target SARS-CoV-2.

作者信息

Tun Zaw Htet, Htike Nang Thinn Thinn, Kyi-Tha-Thu Chaw, Lee Wing-Hin

机构信息

Faculty of Medicine, Royal College of Medicine Perak, Universiti Kuala Lumpur (UniKL RCMP), Ipoh 30450, Perak, Malaysia.

Department of Immunology, Graduate School of Medicine, International University of Health and Welfare, Narita 286-8686, Japan.

出版信息

Pathogens. 2023 Feb 11;12(2):301. doi: 10.3390/pathogens12020301.

DOI:10.3390/pathogens12020301
PMID:36839573
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9967959/
Abstract

Well-trained T-cell immunity is needed for early viral containment, especially with the help of an ideal vaccine. Although most severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-infected convalescent cases have recovered with the generation of virus-specific memory T cells, some cases have encountered T-cell abnormalities. The emergence of several mutant strains has even threatened the effectiveness of the T-cell immunity that was established with the first-generation vaccines. Currently, the development of next-generation vaccines involves trying several approaches to educate T-cell memory to trigger a broad and fast response that targets several viral proteins. As the shaping of T-cell immunity in its fast and efficient form becomes important, this review discusses several interesting vaccine approaches to effectively employ T-cell memory for efficient viral containment. In addition, some essential facts and future possible consequences of using current vaccines are also highlighted.

摘要

早期控制病毒需要训练有素的T细胞免疫,尤其是在理想疫苗的帮助下。尽管大多数感染严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的康复病例通过产生病毒特异性记忆T细胞而康复,但仍有一些病例出现了T细胞异常。几种突变株的出现甚至威胁到第一代疫苗所建立的T细胞免疫的有效性。目前,下一代疫苗的研发涉及尝试多种方法来培育T细胞记忆,以引发针对多种病毒蛋白的广泛而快速的反应。随着以快速高效形式塑造T细胞免疫变得至关重要,本综述讨论了几种有趣的疫苗方法,以有效利用T细胞记忆实现有效的病毒控制。此外,还强调了使用当前疫苗的一些基本事实和未来可能产生的后果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f700/9967959/a5b48f9f29d6/pathogens-12-00301-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f700/9967959/a5b48f9f29d6/pathogens-12-00301-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f700/9967959/a5b48f9f29d6/pathogens-12-00301-g001.jpg

相似文献

1
Employing T-Cell Memory to Effectively Target SARS-CoV-2.利用T细胞记忆有效靶向新冠病毒。
Pathogens. 2023 Feb 11;12(2):301. doi: 10.3390/pathogens12020301.
2
CCR2 Regulates Vaccine-Induced Mucosal T-Cell Memory to Influenza A Virus.CCR2 调节疫苗诱导的流感病毒黏膜 T 细胞记忆。
J Virol. 2021 Jul 12;95(15):e0053021. doi: 10.1128/JVI.00530-21.
3
Association of cellular immunity with severity of COVID-19 from the perspective of antigen-specific memory T cell responses and cross-reactivity.从抗原特异性记忆T细胞反应和交叉反应性角度看细胞免疫与COVID-19严重程度的关联
Inflamm Regen. 2022 Nov 29;42(1):50. doi: 10.1186/s41232-022-00239-1.
4
Virus-specific memory CD8 T cells provide substantial protection from lethal severe acute respiratory syndrome coronavirus infection.病毒特异性记忆 CD8 T 细胞为严重急性呼吸综合征冠状病毒致死性感染提供了实质性保护。
J Virol. 2014 Oct;88(19):11034-44. doi: 10.1128/JVI.01505-14. Epub 2014 Jul 23.
5
The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.新冠病毒-19(Sars-Cov-2)的英国变体不应造成疫苗问题。
J Biol Regul Homeost Agents. 2021 Jan-Feb;35(1):1-4. doi: 10.23812/21-3-E.
6
Vaccine-induced systemic and mucosal T cell immunity to SARS-CoV-2 viral variants.疫苗诱导的针对 SARS-CoV-2 病毒变异株的全身和黏膜 T 细胞免疫。
Proc Natl Acad Sci U S A. 2022 May 17;119(20):e2118312119. doi: 10.1073/pnas.2118312119. Epub 2022 May 13.
7
Long-Term, CD4 Memory T Cell Response to SARS-CoV-2.长期的,针对 SARS-CoV-2 的 CD4 记忆 T 细胞反应。
Front Immunol. 2022 Apr 20;13:800070. doi: 10.3389/fimmu.2022.800070. eCollection 2022.
8
Antibody and Memory B-Cell Immunity in a Heterogeneously SARS-CoV-2-Infected and -Vaccinated Population.在 SARS-CoV-2 异质感染和接种人群中,抗体和记忆 B 细胞免疫。
mBio. 2022 Aug 30;13(4):e0084022. doi: 10.1128/mbio.00840-22. Epub 2022 Jun 23.
9
Host Protective Immunity against Severe Acute Respiratory Coronavirus 2 (SARS-CoV-2) and the COVID-19 Vaccine-Induced Immunity against SARS-CoV-2 and Its Variants.宿主对严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)的保护性免疫与 COVID-19 疫苗诱导的对 SARS-CoV-2 及其变体的免疫。
Viruses. 2022 Nov 17;14(11):2541. doi: 10.3390/v14112541.
10
Memory T cell responses targeting the SARS coronavirus persist up to 11 years post-infection.针对严重急性呼吸综合征冠状病毒的记忆性T细胞反应在感染后持续长达11年。
Vaccine. 2016 Apr 12;34(17):2008-14. doi: 10.1016/j.vaccine.2016.02.063. Epub 2016 Mar 5.

引用本文的文献

1
SARS-CoV-2 virus lacking the envelope and membrane open-reading frames as a vaccine platform.缺乏包膜和膜开放阅读框的严重急性呼吸综合征冠状病毒2(SARS-CoV-2)病毒作为一种疫苗平台
Nat Commun. 2025 May 14;16(1):4453. doi: 10.1038/s41467-025-59533-4.

本文引用的文献

1
Unadjuvanted intranasal spike vaccine elicits protective mucosal immunity against sarbecoviruses.未佐剂化鼻内刺突疫苗引发针对沙贝科病毒的保护性黏膜免疫。
Science. 2022 Nov 25;378(6622):eabo2523. doi: 10.1126/science.abo2523.
2
Emergence of immune escape at dominant SARS-CoV-2 killer T cell epitope.主要 SARS-CoV-2 杀伤性 T 细胞表位出现免疫逃逸。
Cell. 2022 Aug 4;185(16):2936-2951.e19. doi: 10.1016/j.cell.2022.07.002. Epub 2022 Jul 14.
3
Heterologous saRNA Prime, DNA Dual-Antigen Boost SARS-CoV-2 Vaccination Elicits Robust Cellular Immunogenicity and Cross-Variant Neutralizing Antibodies.
异源 saRNA 初免、DNA 双抗原增强 SARS-CoV-2 疫苗接种可诱导强烈的细胞免疫原性和交叉变异体中和抗体。
Front Immunol. 2022 Jul 15;13:910136. doi: 10.3389/fimmu.2022.910136. eCollection 2022.
4
SARS-CoV-2 infection of airway cells causes intense viral and cell shedding, two spreading mechanisms affected by IL-13.SARS-CoV-2 感染气道细胞会导致强烈的病毒和细胞脱落,这两种传播机制都受 IL-13 的影响。
Proc Natl Acad Sci U S A. 2022 Apr 19;119(16):e2119680119. doi: 10.1073/pnas.2119680119. Epub 2022 Mar 30.
5
Dominant CD8 T Cell Nucleocapsid Targeting in SARS-CoV-2 Infection and Broad Spike Targeting From Vaccination.新冠病毒感染中占主导地位的靶向核衣壳的CD8 T细胞及疫苗接种引发的广泛靶向刺突蛋白反应
Front Immunol. 2022 Feb 22;13:835830. doi: 10.3389/fimmu.2022.835830. eCollection 2022.
6
T cell reactivity to the SARS-CoV-2 Omicron variant is preserved in most but not all individuals.大多数但并非所有个体对新冠病毒奥密克戎变种的T细胞反应性得以保留。
Cell. 2022 Mar 17;185(6):1041-1051.e6. doi: 10.1016/j.cell.2022.01.029. Epub 2022 Feb 3.
7
Respiratory mucosal delivery of next-generation COVID-19 vaccine provides robust protection against both ancestral and variant strains of SARS-CoV-2.呼吸道黏膜递呈的新一代 COVID-19 疫苗可对 SARS-CoV-2 的原始株和变异株提供强大保护。
Cell. 2022 Mar 3;185(5):896-915.e19. doi: 10.1016/j.cell.2022.02.005. Epub 2022 Feb 9.
8
Hyperglycemia and Not Hyperinsulinemia Mediates Diabetes-Induced Memory CD8 T-Cell Dysfunction.高血糖而非高胰岛素血症介导糖尿病诱导的记忆性CD8 T细胞功能障碍。
Diabetes. 2022 Apr 1;71(4):706-721. doi: 10.2337/db21-0209.
9
Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa.南非 SARS-CoV-2 奥密克戎变异株的快速流行扩张。
Nature. 2022 Mar;603(7902):679-686. doi: 10.1038/s41586-022-04411-y. Epub 2022 Jan 7.
10
Outbreak caused by the SARS-CoV-2 Omicron variant in Norway, November to December 2021.2021 年 11 月至 12 月,在挪威发生的由 SARS-CoV-2 奥密克戎变异株引起的疫情。
Euro Surveill. 2021 Dec;26(50). doi: 10.2807/1560-7917.ES.2021.26.50.2101147.